Kåre Schultz is Named New President & CEO of Teva Pharmaceutical
Where is Kåre Schultz? | Ctech
Watch CNBC's full interview with Teva CEO Kåre Schultz
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Teva Pharmaceutical CEO on Bringing His Company Back from the Brink | Barron's
Running out of time and money, CEO to prioritize getting Teva out of the hole | The Times of Israel
Ambassador views Teva CEO as important player in potential vaccine alliance
Kåre Schultz - Disability:IN
Teva boss hits out at opioid lawsuits | Financial Times
Teva Appoints New Chief Executive After Months of Speculation - WSJ
Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | Fierce Pharma
Teva Names Kare Schultz as President and Chief Executive Officer - Pharmaceutical Processing World
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva sees return to growth after opioid settlement, shares jump | Reuters
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
Teva Names Kåre Schultz as President and Chief Executive Officer » FINCHANNEL
A Look At Kare Schultz, The New CEO In Charge Of Teva
Teva CEO Kare Schultz's pay fell in 2021 - Globes
Serial Problem Solver
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Troubled Teva Hires CEO with Turnaround Experience - Hamodia.com
Teva CEO on decimated share price: "It's rational enough from a market point of view"
Parsippany-based Teva reaches $225M opioid settlement with Texas - NJBIZ
Israel's Teva Pharm in talks to co-produce COVID-19 vaccines, CEO says
